Data-driven analysis of a validated risk score for ovarian cancer identifies clinically distinct patterns during follow-up and treatment.

Enroth, Stefan; Ivansson, Emma; Lindberg, Julia Hedlund; Lycke, Maria; Bergman, Jessica; Reneland, Anna; Stålberg, Karin; Sundfeldt, Karin; Gyllensten, Ulf

Enroth, Stefan; Ivansson, Emma; Lindberg, Julia Hedlund; Lycke, Maria; Bergman, Jessica; Reneland, Anna; Stålberg, Karin; Sundfeldt, Karin; Gyllensten, Ulf.

Afiliação

Enroth S; Department of Immunology, Genetics, and Pathology, Biomedical Center, SciLifeLab Uppsala, Uppsala University, SE-75108 Uppsala, Sweden.
Ivansson E; Swedish Collegium for Advanced Study, Thunbergsvägen 2, SE-752 38 Uppsala, Sweden.
Lindberg JH; Department of Immunology, Genetics, and Pathology, Biomedical Center, SciLifeLab Uppsala, Uppsala University, SE-75108 Uppsala, Sweden.
Lycke M; Department of Immunology, Genetics, and Pathology, Biomedical Center, SciLifeLab Uppsala, Uppsala University, SE-75108 Uppsala, Sweden.
Bergman J; Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy at Gothenburg University, SE-416 85 Gothenburg, Sweden.
Reneland A; Olink Proteomics AB, Uppsala, Sweden.
Stålberg K; Olink Proteomics AB, Uppsala, Sweden.
Sundfeldt K; Department of Women's and Children's Health, Uppsala University, SE-751 85 Uppsala, Sweden.
Gyllensten U; Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy at Gothenburg University, SE-416 85 Gothenburg, Sweden.

Commun Med (Lond) ; 2: 124, 2022.

Article em En | MEDLINE | ID: mdl-36196264

Palavras-chave

Diagnostic markers; Ovarian cancer; Prognostic markers

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Commun Med (Lond) Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google